When a tool listens to a patient conversation, it handles some of the most sensitive information there is. In this case, privacy isn't a technical detail – it's the fundamental requirement. Here's what pseudonymization means, and why it's at the core of how Medivox is built.


Health information is among the most sensitive personal data available. It is considered a special category of data, and strict requirements apply to how it is processed. When a documentation tool is to listen to a consultation and create a medical record draft, it means that the technology handles precisely this type of data – and then the question of privacy becomes absolutely central.

One word that keeps coming up when talking about secure health data processing is «pseudonymization.» But what does it actually mean, and why is it important? Here's an explanation – and how it relates to the way Medivox is built.

What is pseudonymization?

Pseudonymization is defined in General Data Protection Regulation (GDPR) Article 4 No. 5. In short, it's about processing personal data so that it can no longer be linked to a specific person without the use of additional information – for example, a linking key – which is kept separate and secured.

The Data Protection Agency describes it as the anonymization of personal data so that it cannot be linked to a specific person without additional information that is stored separately and securely. The point is to reduce risk: if data is compromised and cannot be traced back to an individual without the key, the potential for harm is far less.

At the same time, there is one important nuance to remember: pseudonymized data is still considered personal data under the regulations. This is not the same as anonymization, where the link to the individual is permanently removed. Pseudonymization is a risk-reducing measure – one of several building blocks for good privacy protection – not an exemption from the rules. This is precisely why it is a measure highlighted in the regulations on privacy by design.

Why pseudonymization matters for speech-to-text

When a speech-to-text tool is used in a consultation, it may involve processing more information than traditional note-taking, where the practitioner only jots down what is considered relevant and necessary. This is a point that national authorities have also highlighted in their advice on the safe use of AI in documentation. It then becomes crucial how the data is handled from speech to the final draft.

Here, pseudonymization makes a concrete difference. By separating the identity from the content itself before further data processing, the risks associated with processing sensitive information are reduced. This is what makes it possible to adopt modern documentation technology without compromising patient privacy. We have written more about why local anchoring matters in the text about Why medical AI must speak Norwegian – and live in Norway.

This is how Medivox does it

At Medivox, privacy is built in from the ground up. Personal data is pseudonymized before further processing, and all data processing occurs in Norwegian data centers. This means the data remains within Norwegian frameworks, and the identity is separated from the content in the processing chain.

The division of responsibility is equally important. Medivox listens to the consultation and creates a structured draft for the medical record – but it is always you, the healthcare professional, who reviews, corrects, and approves before anything is saved in your own professional system. You own the record and make the final assessment. The tool handles the documentation, not the professional responsibility, and it manages sensitive data in a way designed to reduce risk. These are the same considerations we have written about in the text regarding Psychologists and privacy when AI meets the therapy room, where privacy is particularly vulnerable.

Privacy by design is not an add-on

It's easy to think of privacy as an add-on at the end – a checkbox before launch. But both regulations and good practice point in the opposite direction: privacy should be built in from the start, as part of the architecture itself. Pseudonymization and the choice of where data is processed are not details you tweak afterward. They are decisions that must be made before the first line of code is written.

For you as healthcare personnel, this means you can set clear requirements for the tools you evaluate: How are personal data processed? Where are they stored and processed? And who is responsible for what ultimately ends up in the patient record? These are good questions to ask – and they deserve concrete answers.

Frequently Asked Questions

What is the difference between pseudonymization and anonymization?
With pseudonymization, the information can still be linked to a person using additional information (a key) that is kept separate and secured, and it is still considered personal data. With anonymization, the link is permanently removed.

Is pseudonymized data still personal data?
Yes. Under GDPR, pseudonymized data are still considered personal data, and the regulations apply to them. Pseudonymization is a risk-mitigating measure, not an exemption.

Where is the data processed in Medivox?
All data processing takes place in Norwegian data centers, and personal data is pseudonymized before the data is further processed.

Who is responsible for the journal?
The Medivox draft is created, but it is the healthcare professional who reviews, corrects, and approves it. You own the record and make the final assessment.

Does anonymization mean I don't have to think about privacy?
No. Pseudonymization is an important measure, but privacy is a comprehensive responsibility. Medivox is built to ensure this, but the healthcare provider still has the responsibility for the proper handling of the information.


Use Medivox for freeGet started completely free


Would you like to delve deeper into how Medivox handles privacy and professional responsibility in practice? Contact us – then we'll go through how the solution is built, step by step.


Sources: